• EDITORIAL POLICY
  • ABOUT US
PML Daily
No Result
View All Result
  • Home
  • NEWS
    • Politics
    • Education
    • Regional
    • Africa
    • World
  • INVESTIGATIONS
    • National Archives
    • Special Reports
  • OpEd
  • BUSINESS
    • Agriculture
    • Tech
    • Finance
  • FEATURES
    • Health
    • Tours & Travel
    • Entertainment
    • Society
  • COLUMNISTS
    • The Suited Penguin
  • SPORT
  • Jobs
  • Magazines
  • Home
  • NEWS
    • Politics
    • Education
    • Regional
    • Africa
    • World
  • INVESTIGATIONS
    • National Archives
    • Special Reports
  • OpEd
  • BUSINESS
    • Agriculture
    • Tech
    • Finance
  • FEATURES
    • Health
    • Tours & Travel
    • Entertainment
    • Society
  • COLUMNISTS
    • The Suited Penguin
  • SPORT
  • Jobs
  • Magazines
No Result
View All Result
PML Daily
No Result
View All Result
Home FEATURES Health

Researchers claim breakthrough in COVID- 19 treatment

CONRAD AHABWE | PML Daily Senior CorrespondentbyCONRAD AHABWE | PML Daily Senior Correspondent
June 17, 2020
23 2
28
SHARES
353
VIEWS
FacebookWhatsAppTwitter
Medical personnel secure a sample from a person at a drive-thru COVID-19 testing station at a Kaiser Permanente facility in San Francisco on March 12 (PHOTO/Courtesy).

KAMPALA – Results of a study released on Tuesday show that if common anti-allergy drug dexamethasone is given in low doses to patients battling serious COVID- 19, a third of them can be saved from death.

Conducted by researchers at Oxford university and part of a large Randomized Evaluation of COVID-19 Therapies (RECOVERY) trial that is assessing efficacy of a wide range of drugs, the researchers assessed use of the steroid in 2100 people.

The patients were chosen to randomly receive 6mls of the common drug in a single dose per day either taken orally through an injection for ten days.

In a statement the university notes that results of dexamethasone treatment were compared with 4321 patients randomised in usual care for COVID-19 treatment.

Peter Horby, the lead investigator on the study said the survival benefit was high even in patients who are very sick requiring oxygen treatment which means that the drug can become the standard of care in these patients.

However, this drug will require more evaluation to be enrolled for use among patients as findings are yet to be reviewed by other scientists.

Apart from dexamethasone, other drugs that have been studied for treatment include Ebola drug Remidsivir, anti malarial drugs chloroquine and hydroxychloroquine among others . Though they have been used in treatment of patients, studies have found them not as effective with some finding the drugs to actually increase patient’s risk of death.

Share this:

  • Twitter
  • Facebook

Related

Leave a comment

Tags: coronavirustop

Get real time update about this post categories directly on your device, subscribe now.

Unsubscribe


About

The PML Daily, published via www.pmldaily.com is a publication of Post Media Ltd, a professional Digital/New Media company in Uganda.

Follow us



  • EDITORIAL POLICY
  • ABOUT US

© 2023

No Result
View All Result
  • Home
  • NEWS
    • Politics
    • Education
    • Regional
    • Africa
    • World
  • INVESTIGATIONS
    • National Archives
    • Special Reports
  • OpEd
  • BUSINESS
    • Agriculture
    • Tech
    • Finance
  • FEATURES
    • Health
    • Tours & Travel
    • Entertainment
    • Society
  • COLUMNISTS
    • The Suited Penguin
  • SPORT
  • Jobs
  • Magazines

© 2023

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist